Tower Research Capital (TRC)’s Cantel Medical Corporation CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-4,284
| Closed | -$342K | – | 6282 |
|
|
2021
Q1 | $342K | Sell |
4,284
-127
| -3% | -$9.92K | 0.01% | 1563 |
|
|
2020
Q4 | $348K | Sell |
4,411
-36,881
| -89% | -$2.16M | 0.01% | 1283 |
|
|
2020
Q3 | $1.81M | Buy |
41,292
+30,167
| +271% | +$1.49M | 0.02% | 456 |
|
|
2020
Q2 | $492K | Buy |
11,125
+8,463
| +318% | +$316K | 0.02% | 1055 |
|
|
2020
Q1 | $96K | Buy |
2,662
+2,193
| +468% | +$125K | 0.01% | 1015 |
|
|
2019
Q4 | $33K | Sell |
469
-840
| -64% | -$60.9K | ﹤0.01% | 1612 |
|
|
2019
Q3 | $98K | Sell |
1,309
-630
| -32% | -$53.4K | 0.01% | 1362 |
|
|
2019
Q2 | $156K | Sell |
1,939
-72
| -4% | -$5.06K | 0.01% | 965 |
|
|
2019
Q1 | $135K | Buy |
2,011
+1,547
| +333% | +$117K | 0.01% | 1301 |
|
|
2018
Q4 | $34K | Sell |
464
-3,757
| -89% | -$310K | ﹤0.01% | 1564 |
|
|
2018
Q3 | $389K | Buy |
4,221
+2,546
| +152% | +$243K | 0.03% | 621 |
|
|
2018
Q2 | $164K | Buy |
1,675
+71
| +4% | +$7.94K | 0.01% | 1166 |
|
|
2018
Q1 | $178K | Buy |
+1,604
| New | +$180K | 0.02% | 935 |
|
|
2017
Q4 | – | Sell |
-2,107
| Closed | -$198K | – | 4257 |
|
|
2017
Q3 | $198K | Buy |
+2,107
| New | +$166K | 0.02% | 778 |
|
|
2017
Q1 | – | Sell |
-243
| Closed | -$19K | – | 4235 |
|
|
2016
Q4 | $19K | Sell |
243
-185
| -43% | -$14.4K | ﹤0.01% | 2218 |
|
|
2016
Q3 | $33K | Sell |
428
-4,477
| -91% | -$325K | ﹤0.01% | 1362 |
|
|
2016
Q2 | $337K | Buy |
4,905
+4,805
| +4,805% | +$331K | 0.03% | 399 |
|
|
2016
Q1 | $7K | Sell |
100
-100
| -50% | -$6.28K | ﹤0.01% | 2438 |
|
|
2015
Q4 | $12K | Buy |
200
+100
| +100% | +$6.1K | ﹤0.01% | 1937 |
|
|
2015
Q3 | $6K | Buy |
+100
| New | +$5.29K | ﹤0.01% | 2714 |
|
|
2015
Q2 | – | Sell |
-2,716
| Closed | -$129K | – | 5269 |
|
|
2015
Q1 | $129K | Buy |
+2,716
| New | +$120K | 0.02% | 694 |
|
|
2014
Q4 | – | Sell |
-1,207
| Closed | -$42K | – | 4954 |
|
|
2014
Q3 | $42K | Buy |
+1,207
| New | +$42.6K | ﹤0.01% | 1692 |
|
|
2014
Q1 | – | Sell |
-1,154
| Closed | -$39K | – | 5140 |
|
|
2013
Q4 | $39K | Buy |
+1,154
| New | +$40K | 0.01% | 1617 |
|
|
2013
Q3 | – | Sell |
-1,554
| Closed | -$35K | – | 4956 |
|
|
2013
Q2 | $35K | Buy |
+1,554
| New | +$33.6K | ﹤0.01% | 1225 |
|
Tower Research Capital (TRC)'s CMD Position: Q2 2021 in Review
Tower Research Capital (TRC) sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 4,284 shares — an estimated $342K sold.
Tower Research Capital (TRC) first reported a position in CMD in Q2 2013 and held it in 24 quarters. The position peaked at $1.81M in Q3 2020. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.
- Tower Research Capital (TRC) reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
- Tower Research Capital (TRC) sold 4,284 Cantel Medical Corporation shares in Q2 2021, an estimated $342K.
- Tower Research Capital (TRC) first reported a position in Cantel Medical Corporation in Q2 2013 and held it in 24 quarters.
- Tower Research Capital (TRC)'s Cantel Medical Corporation position peaked at $1.81M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.
Based on Tower Research Capital (TRC)'s 13F filing for Q2 2021, filed 16 Aug 2021.